by Admin | May 18, 2017 | News & Opinions, Science
Stem cells have been lauded for their potential to cure a large array of cell based conditions, from muscular dystrophy to cancer to Parkinson’s Disease. But they have another, lesser known use: as tools for research into how human cells respond to an almost limitless...
by Admin | May 17, 2017 | News & Opinions
What happens when a cell-based therapy gets characterized as a “cure”? A Patient’s Answer May Be Surprising. How is using the word “cure” at this stage of our clinical translation of regenerative medicine likely to impact patients the most? I’ve considered...
by Bernard Siegel | May 4, 2017 | News & Opinions
Fifty years ago in a bygone era, my assignment was to deliver dozens of Smithfield gift hams at Christmastime in the Richmond suburb of Henrico County, Virginia. My father was a real estate developer embroiled in a challenging fight to rezone property for multi-family...
by Admin | Apr 28, 2017 | News & Opinions
4th annual Regenerative Medicine Essentials Course June 5 – 9, 2017, Winston-Salem, North Carolina We at Regenerative Medicine Foundation are proud to be partnering with The Wake Forest Institute for Regenerative Medicine (WFIRM) for the fourth annual...
by Admin | Apr 24, 2017 | News & Opinions, Policy
Everybody loves a good story. It doesn’t really matter if it’s true or false or somewhere in between. For stories, the truth is found in the telling – in the narrative. When we hear a story, we’re as much captured by the way it’s told, the meaning behind the...
by Bernard Siegel | Apr 12, 2017 | News & Opinions, Policy
Columnist Mitchell Hiltzik savaged the La Jolla-based StemGenix Medical Center “The stem cell therapies offered by La Jolla clinic aren’t FDA approved, may not work- and cost $15,000” reads the title of his piece on the LA Times. StemGenix is the subject of a federal...
